| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
460 |
421 |
$25K |
| 84443 |
Thyroid stimulating hormone (TSH) |
2,598 |
2,277 |
$17K |
| 80053 |
Comprehensive metabolic panel |
4,445 |
3,573 |
$16K |
| 96415 |
|
148 |
25 |
$10K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
3,986 |
2,869 |
$8K |
| 90747 |
|
60 |
26 |
$7K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
406 |
58 |
$6K |
| 71046 |
Radiologic examination, chest; 2 views |
544 |
436 |
$6K |
| 96417 |
|
187 |
28 |
$5K |
| 96411 |
|
177 |
30 |
$5K |
| 0012A |
|
135 |
124 |
$5K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
222 |
181 |
$5K |
| 80061 |
Lipid panel |
2,385 |
2,138 |
$5K |
| 0011A |
|
122 |
107 |
$5K |
| 90686 |
|
429 |
184 |
$4K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
1,451 |
1,317 |
$4K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
2,025 |
1,825 |
$4K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
138 |
96 |
$4K |
| 85027 |
|
1,807 |
1,594 |
$3K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
372 |
338 |
$3K |
| 86803 |
|
408 |
361 |
$3K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
304 |
156 |
$3K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
184 |
137 |
$3K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
228 |
214 |
$2K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
578 |
487 |
$2K |
| 81001 |
|
1,997 |
1,750 |
$2K |
| 86706 |
|
526 |
478 |
$2K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
49 |
33 |
$2K |
| 87340 |
|
540 |
484 |
$2K |
| 84153 |
|
409 |
348 |
$2K |
| 90715 |
|
118 |
56 |
$1K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
343 |
282 |
$1K |
| 83655 |
|
189 |
182 |
$1K |
| 84439 |
|
490 |
437 |
$990.61 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
46 |
37 |
$879.47 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
46 |
37 |
$857.18 |
| 84550 |
|
608 |
553 |
$719.74 |
| 73562 |
|
61 |
38 |
$648.38 |
| 82607 |
|
129 |
117 |
$641.08 |
| 82378 |
|
115 |
87 |
$603.64 |
| 86708 |
|
202 |
170 |
$542.60 |
| 82652 |
|
127 |
113 |
$430.34 |
| 82728 |
|
209 |
175 |
$426.04 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
35 |
16 |
$395.19 |
| 84481 |
|
126 |
111 |
$354.85 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
374 |
147 |
$346.50 |
| 85651 |
|
195 |
159 |
$300.62 |
| 87338 |
|
32 |
32 |
$285.90 |
| 82043 |
|
236 |
220 |
$267.25 |
| 86780 |
|
22 |
13 |
$236.39 |
| 72110 |
|
17 |
13 |
$222.30 |
| 81003 |
|
318 |
268 |
$187.57 |
| 82274 |
|
29 |
27 |
$141.96 |
| 73630 |
|
12 |
12 |
$105.18 |
| 84154 |
|
26 |
25 |
$104.70 |
| 72170 |
|
14 |
14 |
$85.30 |
| 82784 |
|
18 |
12 |
$72.04 |
| 85610 |
|
53 |
41 |
$63.74 |
| 88174 |
|
13 |
12 |
$51.82 |
| 86431 |
|
13 |
12 |
$46.29 |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
257 |
145 |
$0.00 |
| 90461 |
|
23 |
14 |
$0.00 |